U.S. Plans to quickly-tune Revamped Covid-19 Vaccines

rapid home Covid-19 exams promise convenience and speed, but the accuracy of the checks rely upon how and in the event you take them. WSJ's Daniela Hernandez explains every little thing you should find out about at-home checking out and how to get correct consequences. Illustration: David Fang and Jacob Reynolds

The Biden administration is preparing to quickly-tune authorization of revamped Covid-19 vaccines to fight Omicron as a analyze from South Africa suggests the fast-spreading variant may cause less severe affliction than its predecessors.

Federal regulators on Sunday said situations were identified in 16 states and that the food and Drug Administration is already in conversations about streamlining authorization for revamped vaccines. company officers have met with vaccine makers and are working to set guidelines for the class of facts that may be mandatory to hastily consider the defense and efficacy of changes to current vaccines.